Clinical trials
Liver Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Unknown status | 8 |
| Recruiting | 7 |
| Terminated | 6 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 5 |
| Bayer | 3 |
| Children's Cancer and Leukaemia Group | 2 |
| LEO Pharma | 2 |
| University College, London | 2 |
| University of Edinburgh | 2 |
| Adaptimmune | 1 |
| Basilea Pharmaceutica | 1 |
| Biogen | 1 |
| Blueprint Medicines Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Neoplasms | 50 |
| Carcinoma, Hepatocellular | 25 |
| Neoplasms | 7 |
| Colorectal Neoplasms | 5 |
| Cholangiocarcinoma | 4 |
| Esophageal Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Stomach Neoplasms | 4 |
| Hepatoblastoma | 3 |
| Liver Diseases | 3 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.